Literature DB >> 29569445

Adversarial Threshold Neural Computer for Molecular de Novo Design.

Evgeny Putin1,2, Arip Asadulaev2, Quentin Vanhaelen1, Yan Ivanenkov1,3,4, Anastasia V Aladinskaya1,3, Alex Aliper1, Alex Zhavoronkov1,5.   

Abstract

In this article, we propose the deep neural network Adversarial Threshold Neural Computer (ATNC). The ATNC model is intended for the de novo design of novel small-molecule organic structures. The model is based on generative adversarial network architecture and reinforcement learning. ATNC uses a Differentiable Neural Computer as a generator and has a new specific block, called adversarial threshold (AT). AT acts as a filter between the agent (generator) and the environment (discriminator + objective reward functions). Furthermore, to generate more diverse molecules we introduce a new objective reward function named Internal Diversity Clustering (IDC). In this work, ATNC is tested and compared with the ORGANIC model. Both models were trained on the SMILES string representation of the molecules, using four objective functions (internal similarity, Muegge druglikeness filter, presence or absence of sp3-rich fragments, and IDC). The SMILES representations of 15K druglike molecules from the ChemDiv collection were used as a training data set. For the different functions, ATNC outperforms ORGANIC. Combined with the IDC, ATNC generates 72% of valid and 77% of unique SMILES strings, while ORGANIC generates only 7% of valid and 86% of unique SMILES strings. For each set of molecules generated by ATNC and ORGANIC, we analyzed distributions of four molecular descriptors (number of atoms, molecular weight, logP, and tpsa) and calculated five chemical statistical features (internal diversity, number of unique heterocycles, number of clusters, number of singletons, and number of compounds that have not been passed through medicinal chemistry filters). Analysis of key molecular descriptors and chemical statistical features demonstrated that the molecules generated by ATNC elicited better druglikeness properties. We also performed in vitro validation of the molecules generated by ATNC; results indicated that ATNC is an effective method for producing hit compounds.

Entities:  

Keywords:  deep neural network; generative adversarial network; molecular de novo design; reinforcement learning

Mesh:

Year:  2018        PMID: 29569445     DOI: 10.1021/acs.molpharmaceut.7b01137

Source DB:  PubMed          Journal:  Mol Pharm        ISSN: 1543-8384            Impact factor:   4.939


  23 in total

1.  Fast fit-free analysis of fluorescence lifetime imaging via deep learning.

Authors:  Jason T Smith; Ruoyang Yao; Nattawut Sinsuebphon; Alena Rudkouskaya; Nathan Un; Joseph Mazurkiewicz; Margarida Barroso; Pingkun Yan; Xavier Intes
Journal:  Proc Natl Acad Sci U S A       Date:  2019-11-12       Impact factor: 11.205

2.  Exploiting machine learning for end-to-end drug discovery and development.

Authors:  Sean Ekins; Ana C Puhl; Kimberley M Zorn; Thomas R Lane; Daniel P Russo; Jennifer J Klein; Anthony J Hickey; Alex M Clark
Journal:  Nat Mater       Date:  2019-04-18       Impact factor: 43.841

3.  Predicting novel drug candidates against Covid-19 using generative deep neural networks.

Authors:  Santhosh Amilpur; Raju Bhukya
Journal:  J Mol Graph Model       Date:  2021-10-13       Impact factor: 2.518

4.  The Commoditization of AI for Molecule Design.

Authors:  Fabio Urbina; Sean Ekins
Journal:  Artif Intell Life Sci       Date:  2022-01-24

Review 5.  Retro Drug Design: From Target Properties to Molecular Structures.

Authors:  Yuhong Wang; Sam Michael; Shyh-Ming Yang; Ruili Huang; Kennie Cruz-Gutierrez; Yaqing Zhang; Jinghua Zhao; Menghang Xia; Paul Shinn; Hongmao Sun
Journal:  J Chem Inf Model       Date:  2022-06-02       Impact factor: 6.162

Review 6.  Relevant Applications of Generative Adversarial Networks in Drug Design and Discovery: Molecular De Novo Design, Dimensionality Reduction, and De Novo Peptide and Protein Design.

Authors:  Eugene Lin; Chieh-Hsin Lin; Hsien-Yuan Lane
Journal:  Molecules       Date:  2020-07-16       Impact factor: 4.411

7.  Optimization of Molecules via Deep Reinforcement Learning.

Authors:  Zhenpeng Zhou; Steven Kearnes; Li Li; Richard N Zare; Patrick Riley
Journal:  Sci Rep       Date:  2019-07-24       Impact factor: 4.379

8.  Efficient multi-objective molecular optimization in a continuous latent space.

Authors:  Robin Winter; Floriane Montanari; Andreas Steffen; Hans Briem; Frank Noé; Djork-Arné Clevert
Journal:  Chem Sci       Date:  2019-07-08       Impact factor: 9.825

Review 9.  Will Artificial Intelligence for Drug Discovery Impact Clinical Pharmacology?

Authors:  Alex Zhavoronkov; Quentin Vanhaelen; Tudor I Oprea
Journal:  Clin Pharmacol Ther       Date:  2020-03-03       Impact factor: 6.875

Review 10.  Allosteric Regulation at the Crossroads of New Technologies: Multiscale Modeling, Networks, and Machine Learning.

Authors:  Gennady M Verkhivker; Steve Agajanian; Guang Hu; Peng Tao
Journal:  Front Mol Biosci       Date:  2020-07-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.